UNSPSC 51111742: Eribulin

This classification denotes a ketones and halichondrin b derivative and antimitotic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LR24G6354G. European Medicines Agency schedules Eribulin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB31134. Eribulin generally arises in the molecular formula C40H59NO11.

The term ERIBULIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 22, no. 1, 2008, list 59.) As of Q4 2014, ERIBULIN remains the US FDA Preferred Term for this commodity. Eribulin bears US NLM identifiers UMLS ID C2350866 and NCI Concept Code C96748. SMILES: CC1CC2CCC3C(=C)CC(O3)CCC45CC6C(O4)C7C(O6)C(O5)C8C(O7)CCC(O8)CC(=O)CC9C(CC(C1=C)O2)OC(C9OC)CC(CN)O.

UNSPSC 51111742 Eribulin, a Commodity code, covers pharmaceutical products procured by state and local health departments and counties for clinical and community health programs. State and local governments purchase this oncology agent and related pharmaceutical inventory through piggyback contracts with established pharmaceutical consortia and through competitive bidding processes to supply hospital systems, public health warehouses, and community health facilities. The issuing bodies include state departments of public health and county health systems, which often leverage cooperative purchasing agreements and pre-negotiated supplier contracts to secure pharmaceuticals at volume pricing.

Recent opportunities show activity in Illinois and Florida. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract to Chartwell Rx LLC on August 28, 2026 (Bid 26-482DPH-PREPD-B-53392) for a total of $2,999,999.11 over the contract term including renewal periods, though this was a completed award through the MMCAP Infuse consortium rather than an open solicitation. Seminole County, Florida issued an IFB (IFB60459723LAS) posted June 30, 2026 with a response deadline of July 26, 2026 (later updated) for procurement of naloxone and drug deactivation systems, requiring 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford; the Seminole County contract included an initial two-year term with one-year renewal option and was potentially funded through FEMA with associated federal compliance requirements. Both solicitations required vendors to meet standard state and local contract compliance standards including drug-free workplace certification and E-Verify confirmation of employee eligibility.